IO Biotech, Inc. (IOBT) Misses Q3 EPS by 7c

IO Biotech, Inc. (NASDAQ: IOBT) reported Q3 EPS of ($0.36), $0.07 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on IO Biotech, Inc. (IOBT) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Venu Holding enters $250 million at-the-market stock offering agreement
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters